Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Roche Aborts But Regeneron, Amgen and Pfizer Sign Up

Aug 08 2016

• By Sukaina Virji

StacksOfPapers_1200x675

Related Content

Advaxis Sinks On Delayed Disclosure Of Clinical Hold

Oct 07 2015

Inovio surprised by Roche returning prostate cancer immunotherapy

Nov 18 2014

Roche licenses two of Inovio's early-stage DNA vaccines

Sep 10 2013

Mayne Cements Place On US Generics Map

Jun 28 2016

Cellectis Success With Off-The-Shelf CAR-T Threatens Kite, Juno, Novartis

Nov 11 2015

Kite Founder Jakobovits Raises $51m For Off-The-Shelf Startup Adicet; Aprecia Prints $35m

Jan 28 2016

Teva Embarks On New Phase With FTC Clearance Of Allergan Generics

Jul 28 2016

Astellas Dips Into Digital Health Via New Venture

Aug 04 2016

CHA, Sorrento JV Highlights Korean Immuno-Oncology Appetite

Aug 04 2016

GSK And Google To Invest £540m In UK-Headquartered Bioelectronics JV

Aug 02 2016

Lupin Buys Shionogi Brands As Japan Market Opens To Indian Firms

Aug 02 2016

Filings Soon As Biogen Snaps Up Ionis' Antisense Treatment

Aug 02 2016

Related Companies

Roche Holding AG

Inovio Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

Adicet Bio Inc.

Kite Pharma, Inc.

Bristol Myers Squibb Company

Novartis AG

Amgen, Inc.

Advaxis, Inc.

Pfizer Inc.

Pelican Technology Holdings, Inc.

Jazz Pharmaceuticals plc

Johnson & Johnson

Carna Biosciences, Inc.

Additional Topics

Commercial Deals BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window